Premium Nahrungsergänzungsmittel | artgerecht

Fatty Acid Binding Markers (FABP) – Definition & Use

Fatty acid binding markers are diagnostic biomarkers released upon tissue damage, indicating injury to organs such as the heart, liver, or intestines.

Regular tips about health Regular tips about health

Things worth knowing about "Fatty acid binding markers"

Fatty acid binding markers are diagnostic biomarkers released upon tissue damage, indicating injury to organs such as the heart, liver, or intestines.

What Are Fatty Acid Binding Markers?

Fatty acid binding markers, commonly known as Fatty Acid Binding Proteins (FABP), are small intracellular proteins found in various tissue types throughout the human body. Their primary role is to transport and bind long-chain fatty acids within cells. Because these proteins are released into the bloodstream when cells are damaged or die, they serve as highly sensitive diagnostic biomarkers for a range of organ and tissue injuries.

Types of Fatty Acid Binding Markers

Several tissue-specific variants of FABP exist, each named according to their tissue of origin:

H-FABP (Heart-type FABP): Found predominantly in cardiac muscle tissue, H-FABP is used as an early biomarker for myocardial infarction (heart attack). Blood levels rise as early as 1 to 3 hours after a cardiac event.
L-FABP (Liver-type FABP): Mainly located in liver cells, L-FABP is a marker for hepatocellular damage, such as that seen in acute hepatitis or toxic liver injury.
I-FABP (Intestinal-type FABP): Present in cells of the small intestine, I-FABP is a sensitive marker for intestinal injury, including conditions such as intestinal ischemia or inflammatory bowel disease.
B-FABP (Brain-type FABP): Expressed in nervous tissue, B-FABP can serve as a marker in cases of neurological damage such as stroke or traumatic brain injury.

Biological Function

FABP proteins fulfill several important metabolic roles. They bind long-chain fatty acids and facilitate their transport within the cell to mitochondria (for energy production) or to the nucleus (for gene regulation). They therefore play a central role in fatty acid metabolism and the maintenance of normal cell function. In addition, they are involved in the regulation of inflammatory processes.

Diagnostic Significance

The clinical value of fatty acid binding markers lies primarily in their early detectability following tissue damage. Compared to classic markers such as troponin or creatine kinase (CK-MB) in myocardial infarction, FABP levels rise more rapidly in the blood and also normalize more quickly. This makes them especially valuable as:

Early diagnostic markers in acute coronary syndrome (H-FABP)
Markers for assessing liver cell damage (L-FABP)
Indicators of intestinal ischemia or intestinal circulation disorders (I-FABP)
Monitoring parameters in critically ill patients in intensive care units

Measurement and Reference Values

FABP levels are measured from a blood sample (serum or plasma), and in certain cases from urine (particularly I-FABP and L-FABP as markers of intestinal or renal injury). Analysis is performed using immunological test methods such as ELISA or point-of-care rapid tests. Under normal circumstances, FABP concentrations in blood are very low. A significant elevation above the reference range indicates acute tissue damage. Exact reference values vary depending on the laboratory and test method used.

Clinical Applications

Fatty acid binding markers are used across various medical specialties:

Cardiology: Early detection of myocardial infarction using H-FABP, particularly in emergency departments
Gastroenterology: Diagnosis of intestinal ischemia and inflammatory bowel disease using I-FABP
Hepatology: Assessment of hepatocellular damage using L-FABP
Nephrology: Urinary L-FABP as an early marker for acute kidney injury
Neurology: B-FABP in suspected brain injury
Intensive Care Medicine: Monitoring organ damage in critically ill patients

Limitations and Considerations

Despite their diagnostic strengths, FABP markers also have certain limitations. Since different tissues produce similar FABP variants, there can occasionally be overlap in interpretation. Furthermore, FABP rapid tests are not yet available in all clinical settings. Results should always be interpreted within the overall clinical context and in combination with other diagnostic measures.

References

Glatz JFC, Luiken JJFP. - From lipid-binding protein to biological target: Fatty acid-binding proteins as mediators of lipid signaling. - Prostaglandins, Leukotrienes and Essential Fatty Acids, 2018.
World Health Organization (WHO) - Biomarkers in risk assessment: Validity and validation. WHO Environmental Health Criteria 222, Geneva, 2001.
Storch J, Thumser AEA. - The fatty acid transport function of fatty acid-binding proteins. - Biochimica et Biophysica Acta, 2000; 1486(1):28–44.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.